ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Vector Science & Therapeutics built a 15-patent-application intellectual property portfolio focused on precision therapeutic delivery. The portfolio is anchored by peptide and biologic administration technologies. The company announced the development.
Tap to vote and see what everyone thinks.
Summary by ByteBrief